Intrauterine Contraceptive Devices (IUD) Market to grow by USD 965.49 million at a CAGR of 3.98% from 2022 to 2027, AbbVie Inc. and Bayer AG are among the key companies - Technavio

2024-02-08
NEW YORK, Feb. 8, 2024 /PRNewswire/ -- The
intrauterine contraceptive devices (IUD) market is estimated to grow by
USD 965.49 million from 2023 to 2027 at a
CAGR of 3.98% according to Technavio. AbbVie Inc., Bayer AG, DKT International, Durbin PLC, EurimPharm Arzneimittel GmbH, EUROGINE SL, Gima Spa, HLL Lifecare Ltd., Krishco Medical Products Pvt. Ltd., Laboratoire HRA Pharma SAS, Melbea Innovations Ltd., Meril Life Sciences Pvt. Ltd., Ocon Medical Ltd., Pregna International Ltd, Prosan International BV, SMB Corp. of India, TESPRO LLC, The Cooper Companies Inc., TRIMEDIC SUPPLY NETWORK Ltd., and Viatris Inc. are key companies. The
Abbvie company offers intrauterine contraceptive devices such as the LILETTA (levonorgestrel-releasing) intrauterine contraceptive.
Continue Reading
Intrauterine Contraceptive Devices (IUD) Market to grow by USD 965.49 million at a CAGR of 3.98% from 2022 to 2027, AbbVie Inc. and Bayer AG are among the key companies - Technavio
Preview
来源: PRNewswire
Technavio has announced its latest market research report titled Global Intrauterine Contraceptive Devices (IUD) Market 2023-2027
To understand more about the information services market, request a Free sample report
The long-term efficacy and increased acceptance of IUDs is a major trend in the market. Global unintended pregnancy rates have declined since the 1990s but remain high and vary across regions. Developed regions have seen faster declines than developing ones. Reduced unplanned pregnancies have lowered abortion rates. Reduced stigma on birth control has led to couples seeking control over childbirth timing and spacing for financial and maternal health reasons. IUDs help space births by preventing unintended pregnancies. Increased awareness of family planning significance leads to higher contraceptive adoption and improved healthcare outcomes for mothers and babies.
North America is projected to contribute
33% of market growth by 2027. The US dominates the market in the region due to local market players, government support, high awareness, and technological innovations like postpartum and reusable IUDs, fueling market growth.
Initiatives by government and non-profit organizations are a key factor driving market growth.
Adverse effects of IUDs is a significant challenge restricting market growth.
Drivers, Trends, and Challenges have an impact on market dynamics and can impact businesses. Find some insights from a free sample report!
Why Buy?
Add credibility to strategy
Analyzes competitor's offerings
Get a holistic view of the market
Grow your profit margin with Technavio- Buy the Report
What are the key data covered in this Intrauterine Contraceptive Devices (IUD) Market report?
CAGR of the market during the forecast period
Detailed information on factors that will drive the growth between 2023 and 2027
Precise estimation of the size and its contribution to the market in focus on the parent market
Accurate predictions about upcoming trends and changes in consumer behavior
Growth across North America, Europe, APAC, and Rest of World (ROW)
A thorough analysis of the market's competitive landscape and detailed information about companies
Comprehensive analysis of factors that will challenge the growth of companies
Technavio's SUBSCRIPTION platform
Intrauterine Contraceptive Devices (IUD): Overview
Intrauterine contraceptive devices (IUDs) are small, T-shaped devices inserted into the uterus to prevent pregnancy. They are a popular form of long-acting reversible contraception (LARC) and offer effective birth control for women. IUDs work by either releasing hormones (hormonal IUDs) or creating a physical barrier to sperm (copper IUDs), providing reliable contraception for several years. They are a key component of women's reproductive health and family planning, offering a safe and convenient option for birth control. The IUD market continues to grow as more women opt for this effective and long-term contraceptive method.
Related Reports
The
Female Contraceptive Market is estimated to grow at a CAGR of 5.32% between 2022 and 2027. The size of the market is forecast to increase by USD 5,142.22 million.
The
aesthetic devices market size is estimated to grow by USD 10,815.68 million at a CAGR of 11.22% between 2022 and 2027.
ToC:
Executive Summary
Market Landscape
Market Sizing
Historic Sizes
Five Forces Analysis
Segmentation by End-user
Segmentation by Type
Segmentation by Geography
Customer Landscape
Geographic Landscape
Drivers, Challenges, & Trends
Company Landscape
Company Analysis
Appendix
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com
SOURCE Technavio
更多内容,请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点,如有版权侵扰或错误之处,请及时联系我们,我们会在24小时内配合处理。
适应症
-
靶点
-
药物
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。